429 related articles for article (PubMed ID: 28388544)
1. The dark side of SOX2: cancer - a comprehensive overview.
Wuebben EL; Rizzino A
Oncotarget; 2017 Jul; 8(27):44917-44943. PubMed ID: 28388544
[TBL] [Abstract][Full Text] [Related]
2. SOX2 in development and cancer biology.
Novak D; Hüser L; Elton JJ; Umansky V; Altevogt P; Utikal J
Semin Cancer Biol; 2020 Dec; 67(Pt 1):74-82. PubMed ID: 31412296
[TBL] [Abstract][Full Text] [Related]
3. SOX2 Is a Marker for Stem-like Tumor Cells in Bladder Cancer.
Zhu F; Qian W; Zhang H; Liang Y; Wu M; Zhang Y; Zhang X; Gao Q; Li Y
Stem Cell Reports; 2017 Aug; 9(2):429-437. PubMed ID: 28793245
[TBL] [Abstract][Full Text] [Related]
4. SOX2 expression is associated with a cancer stem cell state and down-regulation of CDX2 in colorectal cancer.
Lundberg IV; Edin S; Eklöf V; Öberg Å; Palmqvist R; Wikberg ML
BMC Cancer; 2016 Jul; 16():471. PubMed ID: 27411517
[TBL] [Abstract][Full Text] [Related]
5. Linking Pluripotency Reprogramming and Cancer.
Iglesias JM; Gumuzio J; Martin AG
Stem Cells Transl Med; 2017 Feb; 6(2):335-339. PubMed ID: 28191771
[TBL] [Abstract][Full Text] [Related]
6. The multiple roles for Sox2 in stem cell maintenance and tumorigenesis.
Liu K; Lin B; Zhao M; Yang X; Chen M; Gao A; Liu F; Que J; Lan X
Cell Signal; 2013 May; 25(5):1264-71. PubMed ID: 23416461
[TBL] [Abstract][Full Text] [Related]
7. SOX2 function in cancers: Association with growth, invasion, stemness and therapy response.
Mirzaei S; Paskeh MDA; Entezari M; Mirmazloomi SR; Hassanpoor A; Aboutalebi M; Rezaei S; Hejazi ES; Kakavand A; Heidari H; Salimimoghadam S; Taheriazam A; Hashemi M; Samarghandian S
Biomed Pharmacother; 2022 Dec; 156():113860. PubMed ID: 36272267
[TBL] [Abstract][Full Text] [Related]
8. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.
Zhao D; Pan C; Sun J; Gilbert C; Drews-Elger K; Azzam DJ; Picon-Ruiz M; Kim M; Ullmer W; El-Ashry D; Creighton CJ; Slingerland JM
Oncogene; 2015 Jun; 34(24):3107-19. PubMed ID: 25151964
[TBL] [Abstract][Full Text] [Related]
9. Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication.
Kaufhold S; Garbán H; Bonavida B
J Exp Clin Cancer Res; 2016 May; 35():84. PubMed ID: 27225481
[TBL] [Abstract][Full Text] [Related]
10. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.
Fu TY; Hsieh IC; Cheng JT; Tsai MH; Hou YY; Lee JH; Liou HH; Huang SF; Chen HC; Yen LM; Tseng HH; Ger LP
J Oral Pathol Med; 2016 Feb; 45(2):89-95. PubMed ID: 26211876
[TBL] [Abstract][Full Text] [Related]
11. MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer.
Jiang J; Li Z; Yu C; Chen M; Tian S; Sun C
Cancer Lett; 2015 Jan; 356(2 Pt B):962-70. PubMed ID: 25444909
[TBL] [Abstract][Full Text] [Related]
12. SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells.
Rybak AP; Tang D
Cell Signal; 2013 Dec; 25(12):2734-42. PubMed ID: 24036214
[TBL] [Abstract][Full Text] [Related]
13. Understanding the function and regulation of Sox2 for its therapeutic potential in breast cancer.
Dey A; Kundu M; Das S; Jena BC; Mandal M
Biochim Biophys Acta Rev Cancer; 2022 Mar; 1877(2):188692. PubMed ID: 35122882
[TBL] [Abstract][Full Text] [Related]
14. Regulation of colorectal carcinoma stemness, growth, and metastasis by an miR-200c-Sox2-negative feedback loop mechanism.
Lu YX; Yuan L; Xue XL; Zhou M; Liu Y; Zhang C; Li JP; Zheng L; Hong M; Li XN
Clin Cancer Res; 2014 May; 20(10):2631-42. PubMed ID: 24658157
[TBL] [Abstract][Full Text] [Related]
15. Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog).
Lee S; Wottrich S; Bonavida B
Tumour Biol; 2017 Apr; 39(4):1010428317692253. PubMed ID: 28378634
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Cellular Transforming Activity of OCT4, NANOG, and SOX2 in Immortalized Astrocytes.
Seo S; Jeon HY; Kim H
DNA Cell Biol; 2017 Nov; 36(11):1000-1009. PubMed ID: 28933914
[TBL] [Abstract][Full Text] [Related]
17. Predictive Value of Stemness Factor Sox2 in Gastric Cancer Is Associated with Tumor Location and Stage.
Yang L; Xu JF; Kang Q; Li AQ; Jin P; Wang X; He YQ; Li N; Cheng T; Sheng JQ
PLoS One; 2017; 12(1):e0169124. PubMed ID: 28046028
[TBL] [Abstract][Full Text] [Related]
18. Targeting SOX2 in anticancer therapy.
Hüser L; Novak D; Umansky V; Altevogt P; Utikal J
Expert Opin Ther Targets; 2018 Dec; 22(12):983-991. PubMed ID: 30366514
[TBL] [Abstract][Full Text] [Related]
19. Efficient extravasation of tumor-repopulating cells depends on cell deformability.
Chen J; Zhou W; Jia Q; Chen J; Zhang S; Yao W; Wei F; Zhang Y; Yang F; Huang W; Zhang Y; Zhang H; Zhang Y; Huang B; Zhang Z; Jia H; Wang N
Sci Rep; 2016 Jan; 6():19304. PubMed ID: 26787224
[TBL] [Abstract][Full Text] [Related]
20. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
Alberti L; Losi L; Leyvraz S; Benhattar J
PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
